Sirolimus and tuberous sclerosis-associated renal angiomyolipomas

Archives of Disease in Childhood

Volumn 95, Issue 5, 2010, Pages 391-392

  Krischock, L ^a   Beach, R ^b   Taylor, Judy ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; RAPAMYCIN;

ABSENCE OF SIDE EFFECTS; ANGIOMYOLIPOMA; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CHILD; CHROMOSOME ANALYSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FACE TUMOR; FEMALE; HEART TUMOR; HEMANGIOFIBROMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY DISEASE; KIDNEY HYPERTROPHY; KIDNEY SIZE; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PERINATAL PERIOD; PRIORITY JOURNAL; RHABDOMYOMA; SCHOOL CHILD; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; TUBEROUS SCLEROSIS; TUMOR VOLUME; ULTRASOUND;

ANGIOMYOLIPOMA; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; SIROLIMUS; TUBEROUS SCLEROSIS;

EID: 77953792808     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.159210     Document Type: Article

References (6)

1. Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr Nephrol 2005;20:854-7.
2. Hofbauer GF, Marcollo-Pini A, Corsenca A, et al. The mTOR inhibitor rapamycin significantly improves facial angiofi broma lesions in a patient with tuberous sclerosis. Br J Dermatol 2008;159:473-5.
3. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008;358:140-51.
4. Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch 2008;452:119-32.
5. Davies DM, Johnson SR, Tattersfield AE, et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med 2008;358:200-3.
6. Wienecke R, Fackler I, Linsenmaier U, et al. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 2006;48:e27-9.